A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

NCT01165320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis, Esophageal
Candidiasis, Invasive
Aspergillosis

Interventions

DRUG: Caspofungin

Sponsor

Merck Sharp & Dohme LLC